Results

Total Results: 2,327 records

Showing results for "response".

281. Preventing Complications and Treating Symptoms of Diabetic Peripheral Neuropathy (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/diabetic-neuropathy-disposition-170707.pdf
     March 24, 2017 - One trial had no defined primary endpoint and no placebo response. … The other study was a very small crossover study with a small placebo response. … &productid=2436 Published Online: March 24, 2017 10 Commentator & Affiliation Section Comment Response … &productid=2436 Published Online: March 24, 2017 11 Commentator & Affiliation Section Comment Response … &productid=2436 Published Online: March 24, 2017 12 Commentator & Affiliation Section Comment Response

282. Disposition of Comments: CER 228, Nonopioid Pharmacologic Treatments for Chronic Pain (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-228-nonopioid-pharm-chronic-pain-comments.pdf
     April 16, 2020 - nonopioid-chronic-pain/research Published Online: April 16, 2020 2 Commentator & Affiliation Section Comment Response … nonopioid-chronic-pain/research Published Online: April 16, 2020 3 Commentator & Affiliation Section Comment Response … nonopioid-chronic-pain/research Published Online: April 16, 2020 4 Commentator & Affiliation Section Comment Response … nonopioid-chronic-pain/research Published Online: April 16, 2020 5 Commentator & Affiliation Section Comment Response … nonopioid-chronic-pain/research Published Online: April 16, 2020 6 Commentator & Affiliation Section Comment Response

283. Comparative Effectiveness Review Disposition of Comments Report: Anxiety in Children (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/disposition-of-comments-cer-192-anxiety-in-children.pdf
     August 31, 2017 - research-2017/ Published Online: August 31, 2017 Commentator & Affiliation Section Comment Response … research-2017/ Published Online: August 31, 2017 Commentator & Affiliation Section Comment Response … research-2017/ Published Online: August 31, 2017 Commentator & Affiliation Section Comment Response … research-2017/ Published Online: August 31, 2017 Commentator & Affiliation Section Comment Response … research-2017/ Published Online: August 31, 2017 Commentator & Affiliation Section Comment Response

284. Hepatitis-C-Treatment-Adherence Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hepatitis-c-treatment-adherence_executive.pdf
     September 22, 2011 - Response to HCV treatment is typically defined by surrogate virological measures, such as sustained … viral response (SVR) and early viral response (EVR). … , biochemical response (e.g., alanine transaminase [ALT] level), histological response, and patient … Sustained Viral Response Three studies27,34,35 reported SVR. … Early Viral Response One study35 reported EVR for genotype 1 and genotypes 2/3.

285. Template for Reports Developed (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/c-difficile-future_research.pdf
     October 26, 2012 - rates and sustained response rates? … rate and sustained response rate for CDI, harms, time to initial response, duration of CDI therapy … rate and sustained response rate for CDI, harms, time to initial response, duration of CDI therapy … Duration of follow-up of 2 weeks should be sufficient for initial response and 6-8 for sustained response … Duration of follow-up of 2 weeks should be sufficient for initial response and 6-8 for sustained response

286. Making Healthcare Safer IV | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/collections/making-healthcare-safer-IV
     January 01, 2025 - Clinical Decision Support To Prevent Medication Errors and Adverse Drug Events Failure To Rescue – Rapid Response … Safer IV: Final Report on Prioritization of Patient Safety Practices for a New Rapid Review or Rapid Response … Organisms Research Protocol | Sep 7, 2023 Making Healthcare Safer IV: Failure to Rescue—Rapid Response

287. Making Healthcare Safer IV: Use of Report Cards and Outcome Measurements To Improve the Safety of Surgical Care | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/mhs4-surgical-report-cards/research
     February 01, 2024 - The purpose of this rapid response was to summarize recent literature on the use of report cards and … Safer IV: Final Report on Prioritization of Patient Safety Practices for a New Rapid Review or Rapid Response … Organisms Research Protocol | Sep 7, 2023 Making Healthcare Safer IV: Failure to Rescue—Rapid Response

288. Disposition of Comments for Efficacy and Safety of Screening for Postpartum Depression (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_disposition-comments.pdf
     May 01, 2013 - productID=1437 Published Online: April 9, 2013 2 Commentator & Affiliation Section Comment Response … productID=1437 Published Online: April 9, 2013 3 Commentator & Affiliation Section Comment Response … productID=1437 Published Online: April 9, 2013 4 Commentator & Affiliation Section Comment Response … productID=1437 Published Online: April 9, 2013 5 Commentator & Affiliation Section Comment Response … The revised report places a stronger emphasis (partly in response to additional evidence published

289. Disposition of Comments Report for Evaluation and Treatment of Cryptorchidism (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/undescended-testicle_disposition-comments.pdf
     December 11, 2012 - See response above. … No response Peer Reviewer #2 Introduction acceptable No response Peer Reviewer #3 Introduction Page … Peer Reviewer #4 Introduction Excellent - easy to read No response Peer Reviewer #5 Introduction Page … See response below. … See response below.

290. Cancer-Drugs-Utilization-Cost Research (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization-cost_research.pdf
     January 01, 2011 - Among biologic response modifiers, Bacillus Calmette-Guerin (BCG) was most frequently used. … The use of other biologic response modifiers was extremely limited. … The total Medicare reimbursement for biologic response modifiers of interest in 2009 was nearly $21 … See Figure 4 for biologic response modifier-specific trends in reimbursement over the study period. … The total out-of-pocket expense and total drug cost for biologic response modifiers of interest in

291. Disposition of Comments Report for CER 134 Pharmacotherapy for Adults With Alcohol-Use Disorders in Outpatient Settings (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy_disposition-comments.pdf
     May 13, 2014 - The placebo response (perhaps in part a response of AUD to repeated BIs of MM)18,19 might markedly increase … We don’t understand how the placebo + medical management (MM) response in COMBINE is related to the … We have revised the abstract to indicate that our meta-analyses for variation in naltrexone response … As noted in our response above, we have included the study in question here. … Genetics polymorphisms and other factors for personalized response is still not ready for clinicians

292. Procalcitonin for Diagnosis and Management of Sepsis | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/procalcitonin/research-protocol
     December 01, 2019 - Cytokines are released nonspecifically in response to inflammation and infection, but endotoxins are … One comment questioned whether or not pediatric populations will be included in this review; in response … outcomes, such as changes in patient management, duration of antibiotic therapy, length of stay, and response … by using the following string of search terms Procalcitonin (text word) AND “Systemic Inflammatory Response … Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute

293. Disposition of Comments for Quality Improvement Interventions To Address Health Disparities (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/disparities-quality-improvement_disposition-comments.pdf
     August 27, 2012 - displayproduct Published Online: August 27, 2012 2 Commentator & Affiliation Section Comment Response … displayproduct Published Online: August 27, 2012 3 Commentator & Affiliation Section Comment Response … displayproduct Published Online: August 27, 2012 4 Commentator & Affiliation Section Comment Response … displayproduct Published Online: August 27, 2012 5 Commentator & Affiliation Section Comment Response … Please see prior response.

294. Disposition of Comments for CER 178 Newer Medications for Lower Urinary Tract Symptoms (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/prostatic-hyperplasia-medications_disposition-comments.pdf
     May 26, 2016 - productID=2235 Published Online: May 26, 2016 3 Commentator & Affiliation Section Comment Response … productID=2235 Published Online: May 26, 2016 4 Commentator & Affiliation Section Comment Response … TEP Reviewer #1 Results Page 19, line 3: The dose response looks unusual. … Paragraph 2, the responders had a 19 PERCENTAGE POINT increase in response--not 19%. … If true then this is a critical point in the response rates and should be mentioned and the implications

295. Palliative radiation therapy for bone metastases: Update of an ASTRO Evidence-Based Guideline (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/topic-nomination-bone-metastases.pdf
     February 01, 2017 - Majumder et al documented similar response rates in terms of pain response and toxicity of treating spinal … did not correlate with previous response to RT nor did it correlate with dose fractionation.12 Patients … The overall pain response for all sites was 45% for SF and 51% forMF. … (%) Complete response (%) Acute toxicity (%) Subsequent EBRT required (%) Survival Studies using … A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of

296. Drug Therapy for Early Rheumatoid Arthritis in Adults – An Update | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/rheumatoid-arthritis-medicine-update/research-protocol
     September 01, 2019 - The EULAR response criteria are defined as shown in Table 2. Table 2. … DAS28 = Disease Activity Score using 28 joints ≤3.2 Good response Moderate response No … response > 3.2 and ≤ 5.1 Moderate response Moderate response No response > 5.1 Moderate … response No response No response Challenges in Treating Early RA Challenges and controversies … If we do not receive a response, we will not include the study in question.

297. Disposition of Comments for Technical Brief 35: Asthma Self-Management Education Packages (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/tech-brief-35-asthma-self-management-comments.pdf
     April 27, 2020 - https://effectivehealthcare.ahrq.gov/exit-disclaimer/ Summary of Peer Reviewer Comments and Author Response … technical-brief Published Online: April 27, 2020 4 Commentator & Affiliation Section Comment Response … technical-brief Published Online: April 27, 2020 5 Commentator & Affiliation Section Comment Response … technical-brief Published Online: April 27, 2020 6 Commentator & Affiliation Section Comment Response … technical-brief Published Online: April 27, 2020 7 Commentator & Affiliation Section Comment Response

298. Disposition of Comments for CER 177 Agitation Aggression Dementia (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/dementia-agitation-aggression_disposition-comments.pdf
     March 21, 2016 - Commentator & Affiliation Section Comment Response Peer Reviewer #1 Executive Summary I thought … mailto:mfischer@aplushc.com Commentator & Affiliation Section Comment Response Lynn F. … Commentator & Affiliation Section Comment Response Lynn F. … Commentator & Affiliation Section Comment Response G. … Commentator & Affiliation Section Comment Response G.

299. CER 216 Disposition of Comments Report: Telehealth for Acute and Chronic Care Consultations (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-216-telehealth-disposition-comments.pdf
     April 24, 2019 - telehealth-acute-chronic/research Published Online: April 24, 2019 2 Commentator & Affiliation Section Comment Response … telehealth-acute-chronic/research Published Online: April 24, 2019 3 Commentator & Affiliation Section Comment Response … telehealth-acute-chronic/research Published Online: April 24, 2019 4 Commentator & Affiliation Section Comment Response … telehealth-acute-chronic/research Published Online: April 24, 2019 5 Commentator & Affiliation Section Comment Response … May be good to point this out in the response too.

300. Biologic and Nonbiologic Systemic Agents and Phototherapy for Treatment of Chronic Plaque Psoriasis | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/psoriasis-chronic/research
     December 01, 2019 - Services in Persons With Autoimmune Disease Treated With Biologics and Other Immunosuppressants: A Rapid Response … Nov 01, 2024 Linking Dental Services to Treatment Outcomes for Chronic Kidney Disease: A Rapid Response … Product Nov 01, 2024 Linking Dental Services to Treatment Outcomes for Diabetes: A Rapid Response